These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18161540)

  • 1. Design effects for highly clustered count data with varying length of follow-up--applying to the analysis of ICD shocks.
    Wang ZJ
    J Biopharm Stat; 2008; 18(1):31-43. PubMed ID: 18161540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study.
    Varma N
    Am Heart J; 2007 Dec; 154(6):1029-34. PubMed ID: 18035071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shocks, personality, and anxiety in patients with an implantable defibrillator.
    Van den Broek KC; Nyklícek I; Van der Voort PH; Alings M; Denollet J
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):850-7. PubMed ID: 18684282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
    Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
    Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of outcomes for patients receiving implantable cardioverter defibrillators for primary vs secondary-prevention.
    Giedrimas A; Giedrimiene D; Guertin D; White CM; Clyne CA; Kluger J
    Conn Med; 2008; 72(6):329-33. PubMed ID: 18610705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of CRT-ICD: implications for the use of remote follow-up systems. Data from the InSync ICD Italian Registry.
    Lunati M; Gasparini M; Santini M; Landolina M; Perego GB; Pappone C; Marzegalli M; Argiolas C; Murthy A; Valsecchi S;
    Pacing Clin Electrophysiol; 2008 Jan; 31(1):38-46. PubMed ID: 18181908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.
    Almendral J; Arribas F; Wolpert C; Ricci R; Adragao P; Cobo E; Navarro X; Quesada A; ; ;
    Europace; 2008 May; 10(5):528-35. PubMed ID: 18390985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.
    Proclemer A; Ghidina M; Gregori D; Facchin D; Rebellato L; Fioretti P; Brignole M
    Europace; 2009 Apr; 11(4):465-75. PubMed ID: 19136490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy.
    Albert CM; Quigg R; Saba S; Estes NA; Shaechter A; Subacius H; Howard A; Levine J; Kadish A;
    Am Heart J; 2008 Aug; 156(2):367-72. PubMed ID: 18657670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patient with implantable cardioverter-defibrillator follow up--clinic problems].
    Lelakowski J
    Pol Merkur Lekarski; 2009 Jun; 26(156):654-8. PubMed ID: 19711737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy.
    Alsheikh-Ali AA; Homer M; Maddukuri PV; Kalsmith B; Estes NA; Link MS
    J Cardiovasc Electrophysiol; 2008 Aug; 19(8):784-9. PubMed ID: 18284493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size estimation for non-inferiority trials of time-to-event data.
    Crisp A; Curtis P
    Pharm Stat; 2008; 7(4):236-44. PubMed ID: 17583558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter defibrillator therapy: ten years experience in a medical center.
    Chen TE; Wang CC; Chang SH; Yeh SJ; Wu D
    Chang Gung Med J; 2008; 31(1):81-90. PubMed ID: 18419057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.